vancomycin has been researched along with piperacillin, tazobactam drug combination in 167 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.60) | 18.2507 |
| 2000's | 11 (6.59) | 29.6817 |
| 2010's | 88 (52.69) | 24.3611 |
| 2020's | 67 (40.12) | 2.80 |
| Authors | Studies |
|---|---|
| Fraser, SL; Jorgensen, JH | 1 |
| Chua, A; Jimenez, VE; Tortora, G; Younus, F | 1 |
| Beilman, GJ; Feltis, BA; Lee, DA | 1 |
| Akan, H; Calandra, T; Cometta, A; Crokaert, F; De Bock, R; Engelhard, D; Gaya, H; Glauser, MP; Kern, WV; Klastersky, J; Korten, V; Marchetti, O; Padmos, A; Paesmans, M; Skoutelis, A; Vandenbergh, M; Vandercam, M; Viscoli, C; Zinner, S | 1 |
| Dias, MA; Konefal, SH; McLaughlin, MR; Wadie, GM | 1 |
| Boghossian, J; Caputo, W; Dana, A; Gray, S; Harkless, L; Pollak, R; Wu, D | 1 |
| Carmeli, Y; Flores, EL; Lin, MY; Sreeramoju, P; Tolentino, J; Weber, SG; Zumsteg, J | 1 |
| Howell, JM; Mohammadi, A | 1 |
| Hoda, MQ; Hussein, K; Manasia, R; Salahuddin, N; Samad, A; Siddiqui, S; Zafar, A | 1 |
| Aronowitz, P; London, V | 1 |
| MacDougall, C; Oinonen, M; Pakyz, AL; Polk, RE | 1 |
| Akinci, E; Balaban, N; Baran, G; Bodur, H; Cevik, MA; Erbay, A; Onguru, P | 1 |
| Chun, ED; Collins, CD; Malani, PN; Rodgers, PE; Vitale, CA | 1 |
| Bansal, D; Gautam, V; Marwaha, N; Marwaha, RK; Oberoi, S; Sharma, RR | 1 |
| Barshikar, S; Baylor, AE; Dolman, HS; Glowniak, J; Hong, K; Lavery, T; Nailor, M; Singla, R; Stassinopoulus, J; Tyburski, JG; Wilson, RF; Zimmerman, LH | 1 |
| Altunsoy, A; Aypak, C; Azap, A; Balık, I; Ergönül, Ö | 1 |
| Jawitz, RS; Krach, K; Schapiro, B | 1 |
| Holodniy, M; Lucero, CA; Mercier, RC; Nguyen, N; Oda, G; Ryono, RA; Schirmer, PL | 1 |
| Alba, LR; Jia, H; Kubin, CJ; Yoko Furuya, E | 1 |
| Fett, N; Kovarik, CL; Wanat, KA | 1 |
| Adamson, RT; Amara, S; Huang, X; Lew, I | 1 |
| Leung, E; Ly, SC; Scheetz, MH; Venkatesan, N | 1 |
| Finnegan, PM; Hand, S; Linneman, TW; McDonald, JR; Moenster, RP; Thomas, Z | 1 |
| Dilworth, TJ; Dodd, M; Mercier, RC; Ryan, K; Sliwinski, J | 1 |
| Fortier, LC; Garneau, JR; Valiquette, L | 1 |
| Feng, X; He, L; He, Y; Li, C; Liu, H; Liu, X; Ruan, Y; Wu, X; Zhang, Y | 1 |
| Birch, A; Della Vecchia, BJ; Dupree, L; Gomes, DM; Jankowski, CA; Kraemer, DF; Smotherman, C | 1 |
| Burgess, LD; Drew, RH | 1 |
| Dilworth, TJ; Leonard, SN; Mercier, RC; Vilay, AM | 1 |
| Chen, PL; Hung, YP; Ko, WC; Lee, JC; Lin, HJ; Liu, HC; Tsai, PJ; Wu, CJ; Wu, YH; Yeh, FH | 1 |
| Agudelo, M; Gonzalez, JM; Rodriguez, CA; Vesga, O; Zuluaga, AF | 1 |
| Joundi, RA; Leis, JA; Wong, BM | 1 |
| Baines, C; Brown, B; Lewis, I; Smart, D | 1 |
| Cury, JD; Dakkak, M; Siddiqi, F | 1 |
| Bose, S; Popovich, MJ; Silver, BJ; Wurm, E | 1 |
| Davies, SW; Dietch, ZC; Efird, JT; Guidry, CA; Sawyer, RG; Shah, PM; Willis, RN | 1 |
| El-Ibiary, S; Gorlitsky, B | 1 |
| Fodero, KE; Horey, AL; Krajewski, MP; Mergenhagen, KA; Ruh, CA; Sellick, JA | 1 |
| Manek, M; O'Donnell, JN; Rhodes, NJ; Scheetz, MH; Venkatesan, N | 1 |
| Cohen, H; Peyko, V; Smalley, S | 1 |
| Hammond, DA; Lusardi, K; Meena, NK; Painter, JT; Smith, MN | 1 |
| Karino, S; Kaye, KS; Koppula, S; Martin, ET; Murray, KP; Mynatt, RP; Navalkele, B; Nishan, B; Pervaiz, A; Pogue, JM; Rybak, MJ; Salim, M; Shaikh, H; Solanki, S; Tashtoush, N | 1 |
| Carroll, K; Romagnoli, M; Simner, PJ; Wang, F; Workneh, M | 1 |
| Abraham, MK; Crouter, AJ; Wilkerson, RG | 1 |
| Ahrens, CL; Bauer, SR; Bollinger, JE; Harinstein, LM; Petite, SE | 1 |
| Mellen, CK; Rindone, JP; Ryba, JE | 1 |
| Giuliano, CA; Kale-Pradhan, PB; Patel, CR | 1 |
| Burgess, DR; Burgess, DS; Cox, JN; Martin, CA; Rutter, WC | 1 |
| Beardsley, J; Johnson, J; Liu, P; Luther, V; Ohl, C; Williamson, J | 1 |
| Evans, R; Hussain, T; Karino, S; Kaye, KS; Koons, J; Koppula, S; Martin, ET; Murray, KP; Mynatt, RP; Navalkele, B; Nishan, B; Perry, W; Pervaiz, A; Pogue, JM; Rybak, MJ; Salim, M; Shaikh, H; Solanki, S; Tashtoush, N | 1 |
| Cai, Y; Haddad, J; Saqi, A | 1 |
| Compain, F; Guerot, E; Jarraud, S; Podglajen, I; Richaud, C; Rossi, B; Rostane, H | 1 |
| Dubrovskaya, Y; Louie, E; Mousavi, M; Papadopoulos, J; Scipione, MR; Zapolskaya, T | 1 |
| Burgess, DR; Burgess, DS; Rutter, WC; Talbert, JC | 1 |
| Burgess, DS; Rutter, WC | 2 |
| LeCleir, LK; Pettit, RS | 1 |
| Farber, JL; Filippone, EJ; Kraft, WK | 1 |
| Hincapie Castillo, J; Jeon, N; Klinker, KP; Staley, B; Winterstein, AG | 1 |
| De Puy, F; Kay, GN | 1 |
| Effraim, P; Li, L; Tham, SW; Waxman, S | 1 |
| Anderson, CW; Cazares, KS; Denunzio, TM; Lustik, MB; Patel, SM | 1 |
| Fusco, NM; Hassinger, AB; Holsen, MR; Meaney, CJ | 1 |
| Awdishu, L | 1 |
| Bryan, M; Cowden, C; Downes, KJ; Fisher, BT; Goldstein, SL; Gong, W; Huang, YS; Laskin, BL; Zaoutis, TE | 1 |
| Deresinski, S; Watkins, RR | 1 |
| Kempker, RR; Kumar, S; Mgbemena, O; Serota, DP; Weiss, DS; Wozniak, JE | 1 |
| Caffrey, AR; Dosa, D; LaPlante, KL; Lodise, TP; Luther, MK; Timbrook, TT | 1 |
| Abouelkheir, M; Alsubaie, S | 1 |
| Branski, LK; Cambiaso-Daniel, J; Capek, KD; De Crescenzo, A; Finnerty, CC; Herndon, DN; Hundeshagen, G; Killion, EA; Kinsky, MP; Mlcak, RP; Norbury, WB; Sljivich, M; Voigt, CD | 1 |
| Ahmad, I; Bech, CF; Clemmons, AB; Pantin, J | 1 |
| Chu, F; Dunlay, R; Fedullo, P; Le, C; Villar, J; Wardi, G | 1 |
| Bergstrom, C; Gupta, A; Nagalla, S | 1 |
| Adondakis, MG; Brown, EM; Oliver, MR; Skedros, JG | 1 |
| Bartel, BJ; Catlin, JS; Gilder, RE; Kramer, CJ; Mullins, BP | 1 |
| Jaffer, ZN; Nicholson, C | 1 |
| Jafri, SM; Nemakayala, DR; Rai, MP; Rayamajhi, S | 1 |
| Banerjee, R; Cook, KM; Gillon, J; Grisso, AG; Jimenez-Truque, N; Phillips, EJ; Van Driest, SL | 1 |
| Arıcı, M; Balcı, C; Hayran, SA; Ünal, S; Uzun, Ö; Yüce, D | 1 |
| K Heng, Y; Kuan, LY; Lim, YL; Pan, JY; Tan, CH; Tan, LS; Tee, SI | 1 |
| Asseray, N; Bémer, P; Boutoille, D; Corvec, S; Khatchatourian, L; Serandour, N; Takoudju, E; Touchais, S | 1 |
| Chen, XY; Hu, CY; Liu, Y; Xie, XF; Xu, RX; Zhou, X | 1 |
| Gopalakrishnan, M; John, JF; Manappallil, RG; Nambiar, H | 1 |
| Krawczeski, CD; Kwiatkowski, DM; Montez-Rath, ME; Sutherland, SM; Uber, AM | 1 |
| Avendano, EE; Chan, J; Merchant, S; Puzniak, L; Raman, G | 1 |
| Barreto, EF; Kashani, KB; Mara, KC; Nelson, S; Personett, HA; Rule, AD; Sakhuja, A; Schreier, DJ; Steckelberg, JM; Tande, AJ; Tootooni, MS | 1 |
| Hagiwara, D; Kamada, M; Kamimura, H; Miyazaki, M; Moriwaki, N; Nakano, T; Sato, K; Shiotsuka, S; Takata, T; Togawa, A; Toh, H; Tokushige, C | 1 |
| Al Zaibag, M; Aljohany, SM; Alothman, AF; Arabi, YM; Baharoon, S; Balkhy, HH; El-Metwally, A; El-Saed, A | 1 |
| Garcia-Carretero, R | 1 |
| Boslett, BA; Chung, SA; Geha, RM; Manesh, R; Minter, DJ; Ramani, B | 1 |
| Deepak, J; Marciniak, ET; Sameed, M; Sullivan, S | 1 |
| Hagiya, H; Hamaguchi, S; Kokado, R; Morii, D; Okuno, H; Tomono, K; Ueda, A; Yamamoto, N; Yoshida, H | 1 |
| Adams, SM; Babbitt, CJ; Morphew, T; Ngo, L | 1 |
| Joyce, EL; Kane-Gill, SL; Kellum, JA; Ostermann, M; Shi, J | 1 |
| Juang, P; Kollef, MH; Micek, ST | 1 |
| Knezevic, NN; Tinevez, D | 1 |
| Buhlinger, KM; Faircloth, CB; Fuller, KA; Wallace, JR | 1 |
| Burgess, DS; Hall, RG; Rutter, WC | 1 |
| Fuhrman, DY; Joyce, EL; Kane-Gill, SL; Kellum, JA; Priyanka, P | 1 |
| Abe, M; Azuma, M; Chuma, M; Goda, M; Hamano, H; Ishizawa, K; Miki, H; Nakamura, S; Okada, N; Takechi, K; Zamami, Y | 1 |
| Inage, S; Ise, Y; Isoe, Y; Katayama, S; Morishima, M; Murakami, M; Nakamura, S; Nei, T; Okamoto, S; Uetake, S; Yamaguchi, A | 1 |
| Al Qarni, A; Arapis, K; Augustin, P; Grall, N; Montravers, P; Parenti Ribeiro, L; Tanaka, S; Tran-Dinh, A | 1 |
| Li, D; Li, X; Liao, Y; Pan, C; Ren, Y; Shen, S; Wen, A; Zhang, Y | 1 |
| Ide, N; Sato, S; Sawaguchi, K | 1 |
| Cobian, J; Hall, B; Miller, J; Wilson, K | 1 |
| Avedissian, SN; Chalkias, A; d'Aloja, E; Downes, KJ; Fitzgerald, JC; Gilchrist, A; Hiner, D; Liu, J; Locci, E; Lodise, TP; Pais, GM; Prozialeck, WC; Rhodes, NJ; Scheetz, MH; Xanthos, T; Zuppa, AF | 1 |
| Cheung, BMY; Qi, Z; Qin, X; Tsoi, MF; Zhang, L; Zhao, X | 1 |
| Abu Sitta, E; Elsaghir, H; Hollingshead, C; Luttmann, K | 1 |
| Mitsuoka, M; Miwa, R; Sakai, Y; Watanabe, H | 1 |
| Blair, K; Covington, EW | 1 |
| Becker, A; Braun, E; Chaudier, P; Chidiac, C; Corbin, K; Dupieux, C; Ferry, T; Fessy, MH; Goutelle, S; Gunst, S; Laurent, F; Lustig, S; Mabrut, E; Triffault-Fillit, C; Valour, F | 1 |
| Hay, K; Lavana, J; McNamara, JF; O'Callaghan, K | 1 |
| Koff, A; Malinis, M | 1 |
| Courter, J; Dahale, D; Danziger-Isakov, L; Demmel, K; Geller, J; Goldstein, SL; Haslam, DB; O'Brien, M; Young, J | 1 |
| Hagiya, H; Haruki, M; Haruki, Y; Inoue, Y; Sugiyama, T | 1 |
| DeMott, JM; Hammond, DA; Peksa, GD; Traversa, A | 1 |
| Cole, M; Covert, KL; Knoetze, D; Lewis, P | 1 |
| Autry, EB; Beckman, EJ; Gardner, BM; Kuhn, RJ; Saad, A; Schadler, A; Studtmann, AE; Wurth, MA; Young, MR | 1 |
| Brüggemann, RJ; de Wildt, SN; Kolwijck, E; Kramers, C; Schouten, JA; Workum, JD | 1 |
| Busch, DH; Dommasch, M; Feihl, S; Heim, M; Lahmer, T; Lukas, M; Querbach, C; Rothe, K; Schmid, RM; Schneider, G; Schneider, J; Spinner, CD; Treiber, M; Wallnöfer, F; Waschulzik, B; Wurst, M; Zink, A | 1 |
| Dote, S; Horiuchi, N; Inose, R; Kobayashi, Y; Muraki, Y; Sazanami, K | 1 |
| Edwards, JD; Muklewicz, JD; Steuber, TD | 1 |
| Egge, JA; Heintz, BH; Lee, JD; Livorsi, DJ; Lund, BC; Mosher, HJ | 1 |
| Huntul, MA; Kabli, NA; Thabit, AK; Tookhi, RF | 1 |
| Crass, RL; He, M; Matvekas, A; Pai, MP; Souza, E | 1 |
| Canouï, E; Chouchana, L; Contejean, A; Kerneis, S; Tisseyre, M; Treluyer, JM | 1 |
| Blair, M; Côté, JM; Cotter, A; Lynch, B; Murray, PT; Redahan, L | 1 |
| Akova, M; Aslan, AT; Dağ, O; Pashayev, T | 1 |
| Deri, CR; Kimball, JM; Nelson, GE; Nesbitt, WJ; Staub, MB | 1 |
| Burdette, SD; Elliott, BP; Madden, JA; Markert, RJ; Pleiman, CM; Speelmon, EC; Tang, MM | 1 |
| Goldman, JL; Tillman, EM | 1 |
| Hashiguchi, Y; Jono, H; Katanoda, T; Nakata, H; Oda, K; Saito, H | 1 |
| Imai, T; Kakeya, H; Kawaguchi, H; Nagayama, K; Nakamura, Y; Oshima, K; Sakurai, N; Shibata, W; Yamada, K; Yamashita, Y; Yano, T | 1 |
| Duong, L; Harriott, NG; Ives, AL; Pan-Chen, S; Rungkitwattanakul, D | 1 |
| Dote, S; Horiuchi, N; Inose, R; Kobayashi, Y; Muraki, Y; Sazanami, K; Yagi, T | 1 |
| Khalili, H; Mohammadi, M; Mostafavi, Z; Rahmani, H; Salehi, M | 1 |
| Kiliaki, S | 1 |
| Li, T; Liu, K; Mao, H; Ni, J; Wu, B; Xing, C; Xu, X; Zhang, Y | 1 |
| Aizawa, F; Azuma, M; Chuma, M; Goda, M; Hamano, H; Ishizawa, K; Izumi, Y; Nakamoto, A; Okada, N; Yagi, K; Zamami, Y | 1 |
| Cho, H; Kim, JY; Kwak, S | 1 |
| Brateanu, A; Imrey, PB; Le, P; Navaneethan, SD; Pallotta, AM; Patel, P; Rastogi, R; Rothberg, MB; Yu, PC | 1 |
| Agarwal, SK; Buckley, MS; D'Alessio, PA; Kane-Gill, SL; Kobic, E; Komerdelj, IA; Martinez, BK; Rangan, P; Tinta, NC; Yerondopoulos, MJ; Ziadat, DS | 1 |
| Katagiri, H; Mitsuboshi, S | 1 |
| Al-Jebawi, Y; Karalic, K; Mhanna, MJ; Shekhawat, P | 1 |
| Imai, S; Kadomura, S; Kashiwagi, H; Miyai, T; Sato, Y; Sugawara, M; Takekuma, Y | 1 |
| Crass, RL; Fitzgerald, LJ; Han, MK; Jia, S; Lenhan, BE; Lipp, MA; Patel, TS; Simon, RH | 1 |
| Castro-Espinosa, J; Pinzon-Gómez, EM | 1 |
| Agyekum, RS; Anderson, BJ; Cosgriff, CV; Dunn, TG; Giannini, HM; Hennessy, S; Ittner, CAG; Jones, TK; Meyer, NJ; Miano, TA; Oniyide, O; Reilly, JP; Shashaty, MGS; Townsend, R; Turner, AP; Weisman, AR; Wilson, FP; Yang, W | 1 |
| Abruzzi, J; Kopczynski, A; Montes, THM; Nedel, WL; Portela, LV; Rodolphi, MS; Strogulski, NR | 1 |
| Bian, L; He, K; Liang, W; Lv, J; Wu, Z; Yue, H | 1 |
| Baczek, SM; Cohen, JA; Hodge, LA; Ingemi, AI; Kaplan, MC; Kiley, PS; Pearston, AP; Shaeffer, ZA; Soriano, KM; Stanley, JS; Talt, IE; Wilson, TJ; Yao, A | 1 |
| Alosaimy, S; Amaya, L; Biagi, M; Chandler, E; Cubillos, A; Davis, SL; Finch, N; Hobbs, ALV; Holger, D; Jorgensen, SCJ; Kufel, WD; Kunz Coyne, AJ; Lagnf, AM; Li, D; Molina, KC; Moore, WJ; Morrisette, T; Mubarez, M; Patch, M; Polisetty, RS; Rebold, N; Rico, M; Rybak, MJ; Sakoulas, G; Simon, SP; Smith, IMK; Tran, NN; Truong, J; Venugopalan, V; Veve, MP; Witucki, P; Wrin, J; Yost, C | 1 |
| Ankravs, MJ; Bellomo, R; Deane, AM; Rechnitzer, T; Roberts, JA; Sharrock, L; Wallis, SC | 1 |
| Côté, JM; Kane-Gill, SL; Murray, PT | 1 |
| Carta, N; Décaudin, B; Degand, F; Gaudy, R; Genay, S; Lebuffe, G; Martin Mena, A; Maury, É; Négrier, L; Odou, P; Thibaut, M | 1 |
| Cai, Q; Cao, Y; Chen, C; Gao, P; Hou, FF; Hu, Y; Johnson, DW; Kong, Y; Li, G; Li, H; Liu, B; Liu, H; Liu, X; Lu, F; Nie, S; Shen, J; Shi, Y; Su, G; Tang, Y; Wan, Q; Weng, J; Xiao, C; Xie, D; Xu, G; Xu, H; Xu, X; Yang, Q; Zha, Y; Zhou, Y | 1 |
| Caldwell, JT; Dong, S; Fei, L; Goldstein, SL; Hasson, D; Kaplan, J; Slagle, C; Tang Girdwood, S; Tang, P; Vinks, AA | 1 |
| Goldstein, SL; Griffin, BR; Hounkponou, H; Jalal, D; Misurac, J; Reisinger, HS; Vaughan-Sarrazin, M; Wendt, L | 1 |
| Chen, K; Huang, G; Huang, X; Lyu, J; Ma, J; Ma, T; Shi, J; Wang, S; Wei, Y; Xia, J; Zhao, G | 1 |
| Armengol de la Hoz, MÁ; Becker, CD; Calvachi-Prieto, P; Celi, LA; Chen, AY; Chen, C; Dagan, A; Deng, CY; Johnson, AEW; Khazi-Syed, A; Scurlock, C | 1 |
| Fujii, R; Imai, Y; Muranaka, T; Nishiyama, N; Tanaka, M; Tomita, S; Uchitani, K | 1 |
| Furuya, K; Ito, K; Makio, S; Shimada, T; Sugiyama, K | 1 |
| Cotta, MO; Elhadi, M; Farkas, A; Imani, S; Kanji, S; Luque-Pardos, S; Roberts, JA; Sanches, C; Sandaradura, I; Scheetz, MH; Schellack, N; Tabah, A; Timsit, JF; Wilks, K; Williams, PG; Xie, J | 1 |
| Barreto, EF; Chang, J; Lesnicki, E; Marianski, S; Pais, GM; Scheetz, MH; Valdez, K | 1 |
| Akhtar, MF; Akhtar, MM; Alqasoumi, AA; Alshammari, MS; Altaf, U; Altowayan, WM; Batool, N; Godman, B; Haseeb, A; Imam, MT; Raees, F; Saleem, Z | 1 |
| Hanai, Y; Hasegawa, T; Hirayama, S; Kusano, A; Matsumoto, T; Matsuo, K; Nishizawa, K; Shimoyama, K; Uekusa, S; Yokoo, T | 1 |
| Côté, JM; Desjardins, M; Murray, PT | 1 |
12 review(s) available for vancomycin and piperacillin, tazobactam drug combination
| Article | Year |
|---|---|
Mycotic aneurysm of the descending thoracic aorta caused by Pseudomonas aeruginosa in a solid organ transplant recipient: case report and review.
Topics: Adult; Aneurysm, Infected; Aortic Aneurysm, Thoracic; Aztreonam; Blood Vessel Prosthesis Implantation; Debridement; Drug Therapy, Combination; Humans; Infusions, Parenteral; Male; Organ Transplantation; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Secondary Prevention; Treatment Outcome; Vancomycin | 2002 |
Does Piperacillin-Tazobactam Increase the Risk of Nephrotoxicity when Used with Vancomycin: A Meta-Analysis of Observational Trials.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Kidney Diseases; Observational Studies as Topic; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Vancomycin | 2017 |
Is the Combination of Piperacillin-Tazobactam and Vancomycin Associated with Development of Acute Kidney Injury? A Meta-analysis.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2016 |
The Nephrotoxicity of Vancomycin.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Vancomycin | 2017 |
Drug-induced kidney disease in the ICU: mechanisms, susceptibility, diagnosis and management strategies.
Topics: Acute Kidney Injury; Critical Illness; Disease Susceptibility; Drug Therapy, Combination; Humans; Intensive Care Units; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Renal Replacement Therapy; Risk Factors; Vancomycin | 2017 |
Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis.
Topics: Acute Kidney Injury; Adult; Critical Care; Drug Therapy, Combination; Humans; Observational Studies as Topic; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic; Vancomycin | 2018 |
Acute kidney injury associated with concomitant vancomycin and piperacillin/tazobactam administration: a systematic review and meta-analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2018 |
Risk factors for hospitalized patients with resistant or multidrug-resistant
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Critical Care; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Risk Factors; Vancomycin | 2018 |
Vancomycin plus piperacillin/tazobactam and acute kidney injury risk: A review of the literature.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Risk; Vancomycin | 2020 |
Nephrotoxicity from Vancomycin Combined with Piperacillin-Tazobactam: A Comprehensive Review.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Antimicrobial Stewardship; Creatinine; Critical Illness; Drug Therapy, Combination; Humans; Kidney Tubules; Nephritis; Patient Acuity; Piperacillin, Tazobactam Drug Combination; Risk Factors; Vancomycin | 2021 |
Evaluating and Mitigating Risk of Acute Kidney Injury with the Combination of Vancomycin and Piperacillin-Tazobactam in Children.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Risk Factors; Vancomycin | 2021 |
Comparative Prevalence of Acute Kidney Injury in Chinese Patients Receiving Vancomycin with Concurrent β-Lactam Antibiotics: A Retrospective Cohort Study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Bayes Theorem; Cohort Studies; Drug Therapy, Combination; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Retrospective Studies; Vancomycin | 2021 |
5 trial(s) available for vancomycin and piperacillin, tazobactam drug combination
| Article | Year |
|---|---|
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Double-Blind Method; Fever; Humans; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin | 2003 |
An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Diabetic Foot; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sulbactam; Time Factors; Vancomycin; Wound Infection | 2005 |
Prophylactic first-line antibiotics reduce infectious fever and shorten hospital stay during chemotherapy-induced agranulocytosis in childhood acute myeloid leukemia.
Topics: Adolescent; Agranulocytosis; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infection Control; Length of Stay; Leukemia, Myeloid, Acute; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Vancomycin | 2014 |
Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Allografts; Autografts; Cefepime; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Survival Rate; Vancomycin | 2018 |
Intravenous magnesium sulfate for prevention of vancomycin plus piperacillin-tazobactam induced acute kidney injury in critically ill patients: An open-label, placebo-controlled, randomized clinical trial.
Topics: Acute Kidney Injury; Administration, Intravenous; Aged; Critical Illness; Female; Humans; Incidence; Length of Stay; Logistic Models; Magnesium Sulfate; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin | 2021 |
150 other study(ies) available for vancomycin and piperacillin, tazobactam drug combination
| Article | Year |
|---|---|
Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Flavobacterium; Fluoroquinolones; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Reproducibility of Results; Vancomycin | 1997 |
Lemierre's disease caused by co-infection of Arcanobacterium haemolyticum and Fusobacterium necrophorum: a case report.
Topics: Actinomycetales; Actinomycetales Infections; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Fusobacterium Infections; Humans; Jugular Veins; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Thrombophlebitis; Vancomycin | 2002 |
Cervical spondylodiscitis from an ingested pin: a case report.
Topics: Accidents; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Bone Plates; Ceftriaxone; Cervical Vertebrae; Clindamycin; Combined Modality Therapy; Deglutition Disorders; Discitis; Diskectomy; Emergencies; Equipment Contamination; Follow-Up Studies; Foreign Bodies; Humans; Laryngoscopy; Larynx; Male; Neck Pain; Oxacillin; Paresthesia; Penicillanic Acid; Pharynx; Piperacillin; Piperacillin, Tazobactam Drug Combination; Radiography; Recurrence; Retropharyngeal Abscess; Spinal Fusion; Vancomycin; Wounds, Penetrating | 2005 |
Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.
Topics: Anti-Infective Agents; Candida glabrata; Candidiasis; Case-Control Studies; Cross Infection; Female; Fluconazole; Fungemia; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin | 2005 |
Sternal tuberculosis.
Topics: Abscess; Adult; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Humans; Male; Mycobacterium Infections; Mycobacterium tuberculosis; Ofloxacin; Osteomyelitis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sternum; Thorax; Tomography, X-Ray Computed; Tuberculosis; Vancomycin | 2009 |
Impact of antibiotic restriction on broad spectrum antibiotic usage in the ICU of a developing country.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Developing Countries; Drug Prescriptions; Drug Resistance, Microbial; Drug Utilization Review; Humans; Imipenem; Intensive Care Units; Medical Order Entry Systems; Organizational Policy; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Program Development; Vancomycin | 2007 |
Purpuric rash of meningococcemia.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Bacteremia; Ceftriaxone; Humans; Hydrocortisone; Male; Meningococcal Infections; Middle Aged; Neisseria meningitidis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Protein C; Purpura; Recombinant Proteins; Vancomycin | 2008 |
Trends in antibacterial use in US academic health centers: 2002 to 2006.
Topics: Academic Medical Centers; Adult; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; United States; Vancomycin | 2008 |
Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Vancomycin | 2008 |
Antimicrobial use among patients receiving palliative care consultation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Decision Making; Drug Utilization; Female; Humans; Infections; Male; Michigan; Middle Aged; Palliative Care; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Retrospective Studies; Vancomycin | 2010 |
Antithymocyte globulin-induced acute lung injury during transplantation for aplastic anemia.
Topics: Acute Lung Injury; Anemia, Aplastic; Animals; Anti-Bacterial Agents; Antilymphocyte Serum; Bacterial Infections; Bone Marrow Transplantation; Child; Cyclophosphamide; Horses; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Transplantation Conditioning; Vancomycin; Vidarabine | 2011 |
Impact of evaluating antibiotic concentrations in abdominal abscesses percutaneously drained.
Topics: Abdominal Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Exudates and Transudates; Female; Fluconazole; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Suction; Treatment Outcome; Vancomycin | 2011 |
The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cost Savings; Cross Infection; Drug Costs; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Escherichia; Health Policy; Hospitals; Humans; Imipenem; Klebsiella; Meropenem; Methicillin Resistance; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Staphylococcus aureus; Teicoplanin; Thienamycins; Turkey; Vancomycin | 2011 |
A vesiculobullous eruption in a hospitalized patient. Diagnosis: Drug-induced linear IgA bullous dermatosis (LAD) with eosinophils.
Topics: Aged; Anti-Bacterial Agents; Drug Eruptions; Eosinophils; Female; Humans; Immunoglobulin A; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Skin Diseases, Vesiculobullous; Vancomycin | 2011 |
Comparative assessment of antimicrobial usage measures in the Department of Veterans Affairs.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Utilization Review; Hospitals, Veterans; Humans; Imipenem; Meropenem; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins; United States; Vancomycin | 2012 |
Lack of significant variability among different methods for calculating antimicrobial days of therapy.
Topics: Adult; Anti-Infective Agents; Ceftriaxone; Drug Dosage Calculations; Humans; Kidney Diseases; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; Tobramycin; Vancomycin | 2012 |
Pustular eruption in the ICU.
Topics: Acute Generalized Exanthematous Pustulosis; Amputation, Surgical; Anti-Bacterial Agents; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Humans; Intensive Care Units; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Vancomycin | 2012 |
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Cefazolin; Female; Hospitalization; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Skin Diseases, Bacterial; Skin Diseases, Infectious; Sulbactam; Treatment Outcome; Vancomycin | 2013 |
Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusions.
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Administration Schedule; Drug Combinations; Drug Stability; Humans; Infusions, Intravenous; Isotonic Solutions; Nephelometry and Turbidimetry; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; Vancomycin | 2013 |
Acute renal failure associated with vancomycin and β-lactams for the treatment of osteomyelitis in diabetics: piperacillin-tazobactam as compared with cefepime.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Diabetes Complications; Drug Therapy, Combination; Humans; Incidence; Middle Aged; Osteomyelitis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2014 |
Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.
Topics: Anti-Bacterial Agents; Drug Combinations; Drug Synergism; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2014 |
Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clostridioides difficile; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ribotyping; Spores, Bacterial; Tazobactam; Tigecycline; Vancomycin | 2014 |
Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Vancomycin | 2014 |
Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2014 |
Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
Topics: Anti-Bacterial Agents; Drug Synergism; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2014 |
Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection.
Topics: Administration, Oral; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Clostridium; Clostridium Infections; Cytomegalovirus Infections; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2014 |
An optimized mouse thigh infection model for enterococci and its impact on antimicrobial pharmacodynamics.
Topics: Ampicillin; Anaerobiosis; Animals; Anti-Bacterial Agents; Disease Models, Animal; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Mice, Inbred ICR; Microbial Sensitivity Tests; Mucins; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Vancomycin | 2015 |
Antibiotics "just-in-case" in a patient with aspiration pneumonitis.
Topics: Anti-Bacterial Agents; Cerebral Palsy; Clostridioides difficile; Enterocolitis, Pseudomembranous; Epilepsy, Tonic-Clonic; Fatal Outcome; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Aspiration; Radiography; Vancomycin | 2015 |
Performance of the Baxter Infusor LV10 under hyperbaric conditions.
Topics: Anti-Bacterial Agents; Ceftriaxone; Dopamine; Elastomers; Hyperbaric Oxygenation; Infusion Pumps; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Temperature; Time Factors; Vancomycin | 2015 |
Broncholithiasis presenting as bronchiectasis and recurrent pneumonias.
Topics: Anti-Bacterial Agents; Bronchial Diseases; Bronchiectasis; Bronchoalveolar Lavage; Chest Pain; Dyspnea; Female; Fever; Humans; Lithiasis; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Recurrence; Treatment Outcome; Vancomycin | 2015 |
Drug-induced immune-mediated thrombocytopenia in the intensive care unit.
Topics: Device Removal; Female; Humans; Immunoglobulin G; Intensive Care Units; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prosthesis-Related Infections; Purpura, Thrombocytopenic, Idiopathic; Vancomycin | 2015 |
Top Guns: The "Maverick" and "Goose" of Empiric Therapy.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Insufficiency; Retrospective Studies; Risk Assessment; Vancomycin | 2016 |
A Common But Not so Typical Elevated Anion Gap.
Topics: Acetone; Acidosis; Adult; Anti-Bacterial Agents; Blood Glucose; Confusion; Diabetes Complications; Fever; Fluid Therapy; Humans; Leg Injuries; Male; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Sodium Bicarbonate; Staphylococcal Infections; Vancomycin | 2016 |
Impact of an Antimicrobial Stewardship Program on Patient Safety in Veterans Prescribed Vancomycin.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Drug Therapy, Combination; Female; Hospital Departments; Humans; Interrupted Time Series Analysis; Male; Middle Aged; Patient Safety; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin; Veterans | 2016 |
Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations.
Topics: Anti-Bacterial Agents; Chemical Precipitation; Drug Compounding; Drug Incompatibility; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sodium Chloride; Time Factors; Vancomycin | 2016 |
Prospective Comparison of Acute Kidney Injury During Treatment With the Combination of Piperacillin-Tazobactam and Vancomycin Versus the Combination of Cefepime or Meropenem and Vancomycin.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins; Treatment Outcome; Vancomycin | 2017 |
Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Arkansas; Cefepime; Cephalosporins; Critical Illness; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2016 |
Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Michigan; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2016 |
Bypass graft infection and bacteremia caused by Anaerostipes caccae: First report of human infection caused by a recently described gut anaerobe.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anastomosis, Surgical; Anti-Bacterial Agents; beta-Lactams; Blood Culture; Clostridiales; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surgical Wound Infection; Vancomycin | 2016 |
Emphysematous pyelonephritis in a renal allograft.
Topics: Anti-Bacterial Agents; Comorbidity; Diabetes Mellitus; Diabetic Ketoacidosis; Drug Therapy, Combination; Emphysema; Humans; Hypertension; Kidney Transplantation; Male; Middle Aged; Norepinephrine; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Pyelonephritis; Tomography, X-Ray Computed; Transplantation, Homologous; Vancomycin | 2017 |
Antimicrobial Monotherapy versus Combination Therapy for the Treatment of Complicated Intra-Abdominal Infections.
Topics: Academic Medical Centers; Aged; Anti-Bacterial Agents; Cohort Studies; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Intraabdominal Infections; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Time Factors; Treatment Outcome; Vancomycin | 2016 |
Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Humans; Kidney; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2017 |
Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; Sepsis; Vancomycin | 2016 |
Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Middle Aged; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis; Retrospective Studies; Risk; Severity of Illness Index; Vancomycin | 2017 |
Spontaneous Nasal Septal Abscess Presenting as a Soft Tissue Mass in a Child.
Topics: Abscess; Amoxicillin; Anti-Bacterial Agents; Child; Emergency Service, Hospital; Epistaxis; Fever; Humans; Magnetic Resonance Imaging; Male; Methicillin-Resistant Staphylococcus aureus; Nasal Septum; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rupture, Spontaneous; Tomography, X-Ray Computed; Vancomycin | 2017 |
Photo Quiz: A 44-Year-Old Kidney Transplant Patient with Pneumonia.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; beta-Lactamases; Clostridioides difficile; Enterobacter cloacae; Female; Humans; Imipenem; Kidney Failure, Chronic; Kidney Transplantation; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Respiratory Insufficiency; Vancomycin | 2017 |
Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Cohort Studies; Creatinine; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intensive Care Units; Logistic Models; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tertiary Care Centers; Time Factors; Vancomycin | 2017 |
Acute kidney injury in patients treated with vancomycin and piperacillin-tazobactam: A retrospective cohort analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2017 |
Acute Kidney Injury in Patients Treated with IV Beta-Lactam/Beta-Lactamase Inhibitor Combinations.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Vancomycin | 2017 |
Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin | 2017 |
Acute kidney injury risk associated with piperacillin/tazobactam compared with cefepime during vancomycin therapy in hospitalised patients: a cohort study stratified by baseline kidney function.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Assessment; Vancomycin; Young Adult | 2017 |
Electrocardiogram Challenge Syncope in a Woman With Nausea and Diarrhea.
Topics: Aged; Cholecalciferol; Clonazepam; Diarrhea; Esomeprazole; Female; Fluconazole; Humans; Nausea; Ondansetron; Piperacillin, Tazobactam Drug Combination; Syncope; Torsades de Pointes; Vancomycin | 2017 |
Between fire and ice: refractory hypothermia and warmth-induced pain in inherited erythromelalgia.
Topics: Anti-Bacterial Agents; Child; Cold Temperature; Erythromelalgia; Female; Furosemide; Hot Temperature; Humans; Hypothermia; Mutation, Missense; NAV1.7 Voltage-Gated Sodium Channel; Pain; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polyethylene Glycols; Rewarming; Skin Diseases, Vesiculobullous; Sodium Potassium Chloride Symporter Inhibitors; Surface-Active Agents; Thyroxine; Treatment Outcome; Vancomycin | 2017 |
Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Hospitals, Military; Humans; Incidence; Logistic Models; Male; Middle Aged; Military Personnel; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Tertiary Care Centers; Vancomycin | 2017 |
Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Critical Illness; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Intensive Care Units, Pediatric; Logistic Models; Male; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2017 |
Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Databases, Factual; Drug Therapy, Combination; Female; Hospital Mortality; Hospitalization; Humans; Length of Stay; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Assessment; United States; Vancomycin | 2017 |
Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy-What Is the Clinician to Do?
Topics: Anti-Bacterial Agents; Combined Modality Therapy; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Vancomycin | 2017 |
Peculiar purulence: Hypervirulent Klebsiella pneumoniae causing pyomyositis.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Liver Abscess; Male; Middle Aged; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyomyositis; Vancomycin | 2017 |
Pediatric acute kidney injury induced by concomitant vancomycin and piperacillin-tazobactam.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cohort Studies; Databases, Factual; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Infant; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Saudi Arabia; Vancomycin | 2018 |
Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Burns; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Creatinine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Incidence; Infections; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Texas; Vancomycin | 2017 |
Evaluating vancomycin and piperacillin-tazobactam in ED patients with severe sepsis and septic shock.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; California; Drug Therapy, Combination; Emergency Service, Hospital; Female; Hospital Mortality; Humans; Inappropriate Prescribing; Male; Middle Aged; Multivariate Analysis; Piperacillin, Tazobactam Drug Combination; Regression Analysis; Retrospective Studies; Sepsis; Shock, Septic; Vancomycin | 2018 |
Management of Patients With Febrile Neutropenia: A Teachable Moment.
Topics: Acute Kidney Injury; Administration, Intravenous; Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluoroquinolones; Hospitalization; Humans; Medical Overuse; Neoplasm Staging; Piperacillin, Tazobactam Drug Combination; Risk Assessment; Vancomycin | 2018 |
Topics: Anti-Bacterial Agents; Bursitis; Debridement; Elbow Injuries; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Olecranon Process; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propionibacterium acnes; Soft Tissue Injuries; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2018 |
Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2018 |
Bullous eyelid.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Diagnosis, Differential; Eyelid Diseases; Eyelids; Fasciitis, Necrotizing; Female; Humans; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Streptococcal Infections; Streptococcus pyogenes; Vancomycin | 2018 |
Role Of Conservative Management In Emphysematous Gastritis.
Topics: Adult; Anti-Bacterial Agents; Conservative Treatment; Emphysema; Female; Fluid Therapy; Gastric Mucosa; Gastritis; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tomography, X-Ray Computed; Vancomycin | 2018 |
Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin-Tazobactam or Cefepime: A Cohort Study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Multivariate Analysis; Piperacillin, Tazobactam Drug Combination; Regression Analysis; Vancomycin | 2019 |
Nephrotoxicity of piperacillin/tazobactam combined with vancomycin: should it be a concern?
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Drug Therapy, Combination; Female; Humans; Kidney; Logistic Models; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Thienamycins; Vancomycin | 2018 |
Incidence of Acute Kidney Injury among Patients Treated with Piperacillin-Tazobactam or Meropenem in Combination with Vancomycin.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefepime; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2018 |
A polymorphous rash of an uncommon blistering disease.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Betamethasone; Blister; Diagnosis, Differential; Exanthema; Glucocorticoids; Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Male; Piperacillin, Tazobactam Drug Combination; Prednisolone; Treatment Outcome; Vancomycin | 2018 |
Bacteriological relevance of linezolid vs. vancomycin in postoperative empirical treatment of osteoarticular infections: a retrospective single-center study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Female; France; Gram-Positive Bacteria; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Osteoarthritis; Piperacillin, Tazobactam Drug Combination; Prosthesis-Related Infections; Retrospective Studies; Surgical Wound Infection; Vancomycin | 2018 |
Pyopericardium progressing to tamponade in a patient with immune thrombocytopenia.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Cardiac Tamponade; Disease Progression; Drainage; Female; Humans; Penicillanic Acid; Pericardial Effusion; Pericarditis, Constrictive; Piperacillin; Piperacillin, Tazobactam Drug Combination; Purpura, Thrombocytopenic, Idiopathic; Staphylococcal Infections; Staphylococcus aureus; Tomography, X-Ray Computed; Vancomycin | 2018 |
Nephrotoxin exposure and acute kidney injury in critically ill children undergoing congenital cardiac surgery.
Topics: Acute Kidney Injury; Adolescent; Aspirin; Cardiac Surgical Procedures; Child; Child, Preschool; Critical Illness; Enalapril; Female; Heart Defects, Congenital; Humans; Ibuprofen; Infant; Ketorolac; Male; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Retrospective Studies; Vancomycin | 2018 |
Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cohort Studies; Critical Illness; Female; Humans; Intensive Care Units; Kidney Function Tests; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Pseudomonas Infections; Severity of Illness Index; Vancomycin | 2019 |
The impact of earlier intervention by an antimicrobial stewardship team for specific antimicrobials in a single weekly intervention.
Topics: Anti-Infective Agents; Antimicrobial Stewardship; Carbapenems; Daptomycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Teicoplanin; Time Factors; Treatment Outcome; Vancomycin | 2018 |
Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study.
Topics: Adult; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Colistin; Communicable Diseases; Cost-Benefit Analysis; Drug Utilization; Female; Humans; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Population Surveillance; Saudi Arabia; Tertiary Care Centers; Vancomycin; Young Adult | 2018 |
Infectious complications after surgery for a frontal meningioma.
Topics: Aged; Anti-Bacterial Agents; Craniotomy; Drug Resistance, Multiple, Bacterial; Empyema; Enterobacteriaceae Infections; Humans; Male; Meningeal Neoplasms; Meropenem; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Seizures; Spinal Puncture; Staphylococcal Infections; Surgical Wound Infection; Treatment Outcome; Vancomycin | 2019 |
The Right Frame.
Topics: Acute Kidney Injury; Aged; Agriculture; Anti-Bacterial Agents; California; Contrast Media; Cough; Diagnosis, Differential; Dyspnea; Fever; Granulomatosis with Polyangiitis; Humans; Lung Neoplasms; Male; Mexico; Piperacillin, Tazobactam Drug Combination; Pneumonia; Tomography, X-Ray Computed; Vancomycin | 2019 |
Chronic cough and cystic lung disease caused by
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bordetella bronchiseptica; Bordetella Infections; Cough; Humans; Lung; Lymphoma, Large B-Cell, Diffuse; Male; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin; Young Adult | 2019 |
Association of Adverse Drug Events with Broad-spectrum Antibiotic Use in Hospitalized Patients: A Single-center Study.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Vancomycin; Young Adult | 2019 |
Does an Antimicrobial Time-Out Impact the Duration of Therapy of Antimicrobials in the PICU?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Drug Therapy, Combination; Drug Utilization; Duration of Therapy; Female; Humans; Infant; Intensive Care Units, Pediatric; Male; Meropenem; Piperacillin, Tazobactam Drug Combination; Quality of Health Care; Retrospective Studies; Tertiary Care Centers; Vancomycin | 2019 |
Evaluating Renal Stress Using Pharmacokinetic Urinary Biomarker Data in Critically Ill Patients Receiving Vancomycin and/or Piperacillin-Tazobactam: A Secondary Analysis of the Multicenter Sapphire Study.
Topics: Anti-Bacterial Agents; Biomarkers; Critical Illness; Drug Therapy, Combination; Humans; Kidney Diseases; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2019 |
Vancomycin/Piperacillin-tazobactam Nephrotoxicity in the Critically Ill.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Topics: Aged, 80 and over; Anti-Bacterial Agents; Arthritis, Gouty; Citrobacter koseri; Debridement; Diabetic Foot; Enterobacteriaceae Infections; Ertapenem; Humans; Male; Osteomyelitis; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin | 2019 |
Effect of concomitant vancomycin and piperacillin-tazobactam on frequency of acute kidney injury in pediatric patients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Creatinine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Time Factors; Vancomycin | 2019 |
Impact of total body weight on rate of acute kidney injury in patients treated with piperacillin-tazobactam and vancomycin.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Drug Therapy, Combination; Female; Humans; Kentucky; Male; Middle Aged; Obesity; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2019 |
Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Male; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2019 |
Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Drug Interactions; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Multiple Myeloma; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Surveys and Questionnaires; Vancomycin | 2019 |
Acute Kidney Injury in Non-Intensive Care and Intensive Care Patients Treated with Vancomycin and Piperacillin-Tazobactam.
Topics: Acute Kidney Injury; Cohort Studies; Critical Care; Humans; Piperacillin, Tazobactam Drug Combination; Propensity Score; Retrospective Studies; Risk Factors; Vancomycin | 2020 |
Outcome and Adequacy of Empirical Antibiotherapy in Post-Operative Peritonitis: A Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anastomotic Leak; Anti-Bacterial Agents; Ascitic Fluid; Clavulanic Acids; Cohort Studies; Culture Techniques; Digestive System Surgical Procedures; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Hospital Mortality; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Peritonitis; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Prognosis; Retrospective Studies; Surgical Wound Infection; Ticarcillin; Treatment Outcome; Vancomycin | 2020 |
Development and Validation of a Risk Prediction Model of Vancomycin-Associated Nephrotoxicity in Elderly Patients: A Pilot Study.
Topics: Acute Kidney Injury; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Comorbidity; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multivariate Analysis; Pilot Projects; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Assessment; Risk Factors; Staphylococcal Infections; Vancomycin | 2020 |
[Risk of Acute Kidney Injury in Patients Treated with Vancomycin and Piperacillin/Tazobactam Compared to Vancomycin and Meropenem or Doripenem: A Retrospective Cohort Study].
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Doripenem; Drug Therapy, Combination; Female; Humans; Incidence; Logistic Models; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk; Vancomycin | 2019 |
Impact of SEP-1 on broad-spectrum combination antibiotic therapy in the emergency department.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Centers for Medicare and Medicaid Services, U.S.; Early Diagnosis; Early Medical Intervention; Emergency Service, Hospital; Female; Guideline Adherence; Hospital Mortality; Hospitalization; Humans; Male; Medical Overuse; Meropenem; Middle Aged; Patient Care Bundles; Piperacillin, Tazobactam Drug Combination; Reimbursement Mechanisms; Retrospective Studies; Sepsis; Shock, Septic; Soft Tissue Infections; Time-to-Treatment; United States; Urinary Tract Infections; Vancomycin | 2020 |
Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rats; Rats, Sprague-Dawley; Retrospective Studies; Vancomycin | 2020 |
Vancomycin-associated acute kidney injury in Hong Kong in 2012-2016.
Topics: Acute Kidney Injury; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Child, Preschool; Comorbidity; Creatinine; Diuretics; Female; Heart Failure; Hong Kong; Humans; Incidence; Infant; Infant, Newborn; Length of Stay; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Renal Insufficiency, Chronic; Respiratory Insufficiency; Risk Factors; Vancomycin; Young Adult | 2020 |
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus niger; Carcinoma, Squamous Cell; Fungemia; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Thyroid Neoplasms; Vancomycin; Voriconazole | 2020 |
[Combinatorial Vancomycin and Piperacillin/Tazobactam Results in Elevated Vancomycin Trough Concentration and Acute Kidney Injury: A Case Report].
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Interactions; Drug Therapy, Combination; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Piperacillin, Tazobactam Drug Combination; Staphylococcal Infections; Vancomycin | 2020 |
Incidence and Risk Factors of Acute Kidney Injury in Patients Receiving Concomitant Vancomycin and Continuous-Infusion Piperacillin/Tazobactam: A Retrospective Cohort Study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2020 |
Tolerance and microbiological efficacy of cefepime or piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of prosthetic joint infection: a propensity-matched cohort study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cohort Studies; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Acute kidney injury with combination vancomycin and piperacillin-tazobactam therapy in the ICU: A retrospective cohort study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefepime; Critical Care; Duration of Therapy; Female; Humans; Intensive Care Units; Kidney; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Chest Pain and a Cavitary Lung Mass in a Woman With Diabetes.
Topics: Antifungal Agents; Aspergillus niger; Chest Pain; Diabetes Mellitus, Type 2; Empyema, Pleural; Female; Hemoglobin A; Humans; Middle Aged; Piperacillin, Tazobactam Drug Combination; Streptococcus agalactiae; Tomography, X-Ray Computed; Vancomycin; Voriconazole | 2020 |
Reducing acute kidney injury in pediatric oncology patients: An improvement project targeting nephrotoxic medications.
Topics: Acute Kidney Injury; Adolescent; Cefepime; Child; Child, Preschool; Databases, Factual; Febrile Neutropenia; Female; Humans; Infant; Male; Neoplasms; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Concomitant vancomycin and piperacillin/tazobactam treatment is associated with an increased risk of acute kidney injury in Japanese patients.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Japan; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Short Versus Extended Duration Vancomycin and Piperacillin/Tazobactam and the Incidence of Acute Kidney Injury in Noncritically Ill Patients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Incidence; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2021 |
Incidence of nephrotoxicity with prolonged aminoglycoside exposure in patients with cystic fibrosis.
Topics: Acute Kidney Injury; Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Child; Child, Preschool; Colistin; Cystic Fibrosis; Female; Humans; Incidence; Infant; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Retrospective Studies; Risk Factors; Tobramycin; Vancomycin; Young Adult | 2020 |
Nephrotoxicity of concomitant piperacillin/tazobactam and teicoplanin compared with monotherapy.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Teicoplanin; Vancomycin | 2021 |
Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Antimicrobial Stewardship; Aspergillosis; Azithromycin; Bacterial Infections; Cohort Studies; Coinfection; COVID-19; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Germany; Humans; Klebsiella Infections; Linezolid; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Retrospective Studies; SARS-CoV-2; Staphylococcal Infections; Streptococcal Infections; Sulbactam; Vancomycin; Young Adult | 2021 |
Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin trough concentration.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2021 |
Evaluation of area under the concentration-time curve-guided vancomycin dosing with or without piperacillin-tazobactam on the incidence of acute kidney injury.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Area Under Curve; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin | 2021 |
Risk of Acute Kidney Injury and Clostridioides difficile Infection With Piperacillin/Tazobactam, Cefepime, and Meropenem With or Without Vancomycin.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Clostridioides; Drug Therapy, Combination; Humans; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2021 |
Impact of combining vancomycin with piperacillin/tazobactam or with meropenem on vancomycin-induced nephrotoxicity.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Saudi Arabia; Vancomycin | 2021 |
Alteration in Acute Kidney Injury Potential with the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Cilastatin, Imipenem Drug Combination; Drug Therapy, Combination; Male; Mice; Mice, Inbred C57BL; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2021 |
Combination of vancomycin plus piperacillin and risk of acute kidney injury: a worldwide pharmacovigilance database analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Pharmacovigilance; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2021 |
Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Bacterial Agents; Female; Humans; Kidney; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Teicoplanin; Tertiary Care Centers; Vancomycin | 2021 |
Development of the Three Antimicrobial Stewardship E's (TASE) Framework and Association Between Stewardship Interventions and Intended Results Analysis to Identify Key Facility-Specific Interventions and Strategies for Successful Antimicrobial Stewardship
Topics: Adult; Anti-Bacterial Agents; Antimicrobial Stewardship; Hospitalization; Humans; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2021 |
A retrospective cohort study assessing acute kidney injury and renal recovery among septic patients empirically treated with vancomycin piperacillin-tazobactam versus vancomycin cefepime.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Lowered Risk of Nephrotoxicity through Intervention against the Combined Use of Vancomycin and Tazobactam/Piperacillin: A Retrospective Cohort Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2021 |
Risk factors for acute kidney injury in vancomycin and piperacillin/tazobactam combination therapy: A retrospective study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin | 2021 |
Comparative incidence of acute kidney injury in patients on vancomycin therapy in combination with cefepime, piperacillin-tazobactam or meropenem.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Cefepime; Drug Therapy, Combination; Humans; Incidence; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2022 |
Incidence of acute kidney injury after teicoplanin- or vancomycin- and piperacillin/tazobactam combination therapy: A comparative study using propensity score matching analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cohort Studies; Drug Therapy, Combination; Humans; Incidence; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propensity Score; Retrospective Studies; Teicoplanin; Vancomycin | 2021 |
Piperacillin-Tazobactam-Induced Immune Thrombocytopenia: A Case Report.
Topics: Anti-Bacterial Agents; Humans; Piperacillin, Tazobactam Drug Combination; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia; Vancomycin | 2023 |
Impact of Area Under the Concentration-Time Curve on the Prevalence of Vancomycin-Induced Nephrotoxicity in Combination With Tazobactam/Piperacillin or Cefepime: A Single-Institution Retrospective Study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bayes Theorem; Cefepime; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Retrospective Studies; Vancomycin | 2021 |
Vancomycin-induced nephrotoxicity in non-intensive care unit pediatric patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Infant; Intensive Care Units; Male; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Seoul; Tertiary Care Centers; Vancomycin; Young Adult | 2021 |
Association of antibiotic use and acute kidney injury in patients hospitalized with community-acquired pneumonia.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Female; Humans; Macrolides; Male; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; Vancomycin | 2022 |
Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Cefepime; Cohort Studies; Critical Illness; Drug Therapy, Combination; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propensity Score; Retrospective Studies; Vancomycin | 2022 |
Risk of kidney injury in patients on concomitant oral vancomycin and piperacillin-tazobactam: Analysis of the pharmacovigilance database in Japan.
Topics: Acute Kidney Injury; Administration, Oral; Age Factors; Aged; Aged, 80 and over; Databases as Topic; Drug Therapy, Combination; Female; Humans; Japan; Male; Middle Aged; Pharmacovigilance; Piperacillin, Tazobactam Drug Combination; Risk Factors; Sex Factors; Vancomycin | 2022 |
The concomitant use of vancomycin and piperacillin-tazobactam is associated with acute kidney injury (AKI) in extremely low birth weight infants (ELBW).
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Using Japanese big data to investigate novel factors and their high-risk combinations that affect vancomycin-induced nephrotoxicity.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Big Data; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Japan; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2022 |
Acute kidney injury in cystic fibrosis patients treated with intravenous colistimethate sodium or tobramycin.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin | 2022 |
[Antibiotic consumption surveillance in 10 health institutions between 2013 and 2020 in Colombia].
Topics: Anti-Bacterial Agents; Ceftriaxone; Colombia; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Vancomycin | 2022 |
Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Biomarkers; Cefepime; Creatinine; Critical Illness; Cystatin C; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Renal Dialysis; Retrospective Studies; Vancomycin | 2022 |
Antibiotic therapy does not alter mitochondrial bioenergetics in lymphocytes of patients with septic shock - A prospective cohort study.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clavulanic Acid; Energy Metabolism; Humans; Lymphocytes; Meropenem; Mitochondria; Piperacillin, Tazobactam Drug Combination; Polymyxins; Prospective Studies; Shock, Septic; Vancomycin | 2022 |
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Aorta; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Thrombocytopenia; Vancomycin | 2022 |
Retrospective Cohort Study of the Incidence of Acute Kidney Injury with Vancomycin Area under the Curve-Based Dosing with Concomitant Piperacillin-Tazobactam Compared to Meropenem or Cefepime.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Drug Therapy, Combination; Humans; Incidence; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2022 |
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Vancomycin | 2023 |
Clearance of Piperacillin-Tazobactam and Vancomycin During Continuous Renal Replacement With Regional Citrate Anticoagulation.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anticoagulants; Citrates; Citric Acid; Critical Illness; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Vancomycin | 2023 |
A ray of hope in the discord: is adding piperacillin-tazobactam to vancomycin truly more nephrotoxic?
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2022 |
Simultaneous infusion of two incompatible antibiotics: Impact of the choice of infusion device and concomitant simulated fluid volume support on the particulate load and the drug mass flow rates.
Topics: Anti-Bacterial Agents; Drug Incompatibility; Infusions, Intravenous; Infusions, Parenteral; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2022 |
Piperacillin/tazobactam and risk of acute kidney injury in adults hospitalized with infection without vancomycin: a multi-centre real-world data analysis.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Ceftazidime; Data Analysis; Drug Therapy, Combination; Female; Humans; Meropenem; Middle Aged; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2023 |
Relationship between piperacillin concentrations, clinical factors and piperacillin/tazobactam-associated acute kidney injury.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Vancomycin; Young Adult | 2023 |
Nephrotoxin Exposure and Acute Kidney Injury in Adults.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Child; Hospitalization; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2023 |
Comparative analysis of pathogen distribution in patients with fracture-related infection and periprosthetic joint infection: a retrospective study.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Arthritis, Infectious; Humans; Piperacillin, Tazobactam Drug Combination; Prosthesis-Related Infections; Retrospective Studies; Staphylococcus; Vancomycin | 2023 |
A Large-Scale Multicenter Retrospective Study on Nephrotoxicity Associated With Empiric Broad-Spectrum Antibiotics in Critically Ill Patients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Critical Illness; Drug Therapy, Combination; Humans; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2023 |
[A Case of Thrombocytopenia Following Minocycline Administration].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Female; Humans; Minocycline; Piperacillin, Tazobactam Drug Combination; Thrombocytopenia; Vancomycin | 2023 |
A case of Robinsoniella peoriensis bacteremia during using piperacillin-tazobactam.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Female; Fever; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2023 |
International survey of antibiotic dosing and monitoring in adult intensive care units.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Critical Illness; Cross-Sectional Studies; Humans; Intensive Care Units; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surveys and Questionnaires; Vancomycin | 2023 |
Iohexol-Measured Glomerular Filtration Rate and Urinary Biomarker Changes between Vancomycin and Vancomycin Plus Piperacillin-Tazobactam in a Translational Rat Model.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Biomarkers; Drug Therapy, Combination; Glomerular Filtration Rate; Iohexol; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rats; Rats, Sprague-Dawley; Retrospective Studies; Vancomycin | 2023 |
Using Culture Sensitivity Reports to Optimize Antimicrobial Therapy: Findings and Implications of Antimicrobial Stewardship Activity in a Hospital in Pakistan.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Hospitals; Humans; Linezolid; Pakistan; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2023 |
Vancomycin Hydrochloride as a Risk Factor for Acute Kidney Injury: A Retrospective Study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin | 2023 |
Does Vancomycin-Piperacillin-Tazobactam Cause Pseudo-AKI, True Nephrotoxicity, or Both?
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2023 |